These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 23823941

  • 1. Inhibition of the Fe(III)-catalyzed dopamine oxidation by ATP and its relevance to oxidative stress in Parkinson's disease.
    Jiang D, Shi S, Zhang L, Liu L, Ding B, Zhao B, Yagnik G, Zhou F.
    ACS Chem Neurosci; 2013 Sep 18; 4(9):1305-13. PubMed ID: 23823941
    [Abstract] [Full Text] [Related]

  • 2. Norepinephrine-Fe(III)-ATP Ternary Complex and Its Relevance to Parkinson's Disease.
    Kou L, Duan Y, Wang P, Fu Y, Darabedian N, He Y, Jiang D, Chen D, Xiang J, Liu G, Zhou F.
    ACS Chem Neurosci; 2019 Jun 19; 10(6):2777-2785. PubMed ID: 31059226
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The role of transition metals in the pathogenesis of Parkinson's disease.
    Kienzl E, Puchinger L, Jellinger K, Linert W, Stachelberger H, Jameson RF.
    J Neurol Sci; 1995 Dec 19; 134 Suppl():69-78. PubMed ID: 8847547
    [Abstract] [Full Text] [Related]

  • 5. Cu(II)-catalyzed oxidation of dopamine in aqueous solutions: mechanism and kinetics.
    Pham AN, Waite TD.
    J Inorg Biochem; 2014 Aug 19; 137():74-84. PubMed ID: 24815905
    [Abstract] [Full Text] [Related]

  • 6. Uric acid is reduced in the substantia nigra in Parkinson's disease: effect on dopamine oxidation.
    Church WH, Ward VL.
    Brain Res Bull; 1994 Aug 19; 33(4):419-25. PubMed ID: 8124580
    [Abstract] [Full Text] [Related]

  • 7. Protective effects of riluzole on dopamine neurons: involvement of oxidative stress and cellular energy metabolism.
    Storch A, Burkhardt K, Ludolph AC, Schwarz J.
    J Neurochem; 2000 Dec 19; 75(6):2259-69. PubMed ID: 11080177
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Nitration of soluble proteins in organotypic culture models of Parkinson's disease.
    Larsen TR, Söderling AS, Caidahl K, Roepstorff P, Gramsbergen JB.
    Neurochem Int; 2008 Feb 19; 52(3):487-94. PubMed ID: 17900761
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Iron as catalyst for oxidative stress in the pathogenesis of Parkinson's disease?
    Kienzl E, Jellinger K, Stachelberger H, Linert W.
    Life Sci; 1999 Feb 19; 65(18-19):1973-6. PubMed ID: 10576448
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease.
    Duda J, Pötschke C, Liss B.
    J Neurochem; 2016 Oct 19; 139 Suppl 1(Suppl Suppl 1):156-178. PubMed ID: 26865375
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of siRNA-induced silencing of cellular prion protein on tyrosine hydroxylase expression in the substantia nigra of a rat model of Parkinson's disease.
    Wang X, Yang HA, Wang XN, Du YF.
    Genet Mol Res; 2016 May 09; 15(2):. PubMed ID: 27173342
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Kir6.1/K-ATP channel on astrocytes protects against dopaminergic neurodegeneration in the MPTP mouse model of Parkinson's disease via promoting mitophagy.
    Hu ZL, Sun T, Lu M, Ding JH, Du RH, Hu G.
    Brain Behav Immun; 2019 Oct 09; 81():509-522. PubMed ID: 31288070
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.